Various Diseases and Clinical Heterogeneity Are Associated With “Hot Cross Bun”

Abstract

Objective: To characterize the clinical phenotypes associated with the “hot cross bun” sign (HCBs) on MRI and identify correlations between neuroimaging and clinical characteristics.Methods: Firstly, we screened a cohort of patients with HCBs from our radiologic information system (RIS) in our center. Secondly, we systematically reviewed published cases on HCBs and classified all these cases according to their etiologies. Finally, we characterized all HCBs cases in detail and classified the disease spectra and their clinical heterogeneity.Results: Out of a total of 3,546 patients who were screened, we identified 40 patients with HCBs imaging sign in our cohort; systemic literature review identified 39 cases, which were associated with 14 diseases. In our cohort, inflammation [neuromyelitis optica spectrum disorders (NMOSD), multiple sclerosis (MS), and acute disseminated encephalomyelitis (ADEM)] and toxicants [toxic encephalopathy caused by phenytoin sodium (TEPS)] were some of the underlying etiologies. Published cases by systemic literature review were linked to metabolic abnormality, degeneration, neoplasm, infection, and stroke. We demonstrated that the clinical phenotype, neuroimaging characteristics, and HCBs response to therapy varied greatly depending on underlying etiologies.Conclusion: This is the first to report HCBs spectra in inflammatory and toxication diseases. Our study and systemic literature review demonstrated that the underpinning disease spectrum may be broader than previously recognized.

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment

“…Studies by our group and other researchers have suggested that neuroinflammation is of considerable importance in the pathologic process of PD (4)(5)(6)(7)(8)(9)(10)(11)(12). In PD, neuroinflammatory cells are composed of hyperplastic reactive glial cells, especially microglia and astrocytes, the essential components of the neurovascular unit (NVU) (13).…”

Retinal Nerve Fiber Layer Thickness and Associations With Cognitive Impairment in Parkinson’s Disease

“…Parkinson’s disease (PD) is a highly prevalent neurodegenerative disorder worldwide with characteristic motor dysfunctions including bradykinesia, stiffness and resting tremor ( Tolosa et al, 2021 ). Ours and other studies have indicated that some indicators such as neuroinflammatory, neuroimaging mediators and serum neurofilament light chain are usually applied as markers in diagnosing and evaluating the progression and severity of PD and PD Syndromes ( Wang et al, 2020 , 2021 ; Yang et al, 2020 ; Zhu et al, 2020 , 2021a ; Bestwick et al, 2021 ; Liu et al, 2021 ; Quadalti et al, 2021 ). Identifying potential biomarkers for early diagnosis and assessment is one of the research hotspots in the field of PD ( Avenali et al, 2020 ; Papuć and Rejdak, 2020 ; Ma et al, 2021 ).…”

The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease

“…Cognitive impairment, including impairment in attention, executive function, memory, speech, and visual perception, is a common and salient manifestation of Parkinson's disease (PD) and interferes with the ability to perform activities of daily living and patient outcomes 1–6 . Our recent studies have demonstrated various neuroimaging markers and their relative neuropathogenesis in PD and PD Syndromes (PDS), which appear to contribute to motor/non‐motor dysfunctions and discriminative aspects 7–12 . According to the degree of cognitive impairment, 13,14 PD patients can be classified into those with PD with normal cognition (PD‐NC), PD with mild cognitive impairment (PD‐MCI), and PD with dementia (PDD).…”